S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 36,850
+2,250 (6.50%)
At close: Apr 29, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 456.39 billion as of April 30, 2026. Its market cap has increased by 68.21% in one year.
Market Cap
456.39B
Enterprise Value
461.98B
Revenue
16.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
36,850.00
Market Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 456.39B, an increase of 120.95%. That is a compound annual growth rate of 30.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 456.39B | 0.64% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 603.13B |
| Kanaph Therapeutics | 517.17B |
| HansBiomed | 472.76B |
| Kangstem Biotech | 383.27B |
| curacle co.,ltd. | 378.57B |
| Y-Biologics | 351.37B |
| TiumBio | 348.94B |
| NIBEC | 314.32B |